Apogee Therapeutics reports Q2 results

1 hour ago 1

Apogee Therapeutics press release (NASDAQ:APGE): Q2 Net loss was $66.1 million for the quarter ended June 30, 2025, compared to a net loss of $33.8 million for the quarter ended June 30, 2024.
Cash, cash equivalents and marketable securities were $621.2 million as of June 30, 2025, compared to $681.4 million as of March 31, 2025.

Recommended For You